copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
HAEGARDA | C1 Esterase Inhibitor Subcutaneous (Human) Important Safety Information HAEGARDA ®, C1 Esterase Inhibitor Subcutaneous (Human), is a plasma-derived concentrate of C1 Esterase Inhibitor (C1-INH) indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older HAEGARDA is for subcutaneous use after reconstitution only
Package Insert - HAEGARDA See full prescribing information for HAEGARDA HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) For Subcutaneous Injection, Freeze-Dried Powder for Reconstitution Initial U S Approval: 2017
HIGHLIGHTS OF PRESCRIBING INFORMATION . . . 1 INDICATIONS AND USAGE HAEGARDA is a plasma-derived concentrate of C1 Esterase Inhibitor (Human) (C1-INH) indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older 2 DOSAGE AND ADMINISTRATION After reconstitution, for subcutaneous use only HAEGARDA is intended for self (or caregiver)-administration after reconstitution at a dose of
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION 2 CONTRAINDICATIONS HAEGARDA (C1 Esterase Inhibitor Subcutaneous (Human)) is contraindicated in individuals who have experienced life-threatening hypersensitivity reactions, including anaphylaxis, to C1 Esterase Inhibitor (C1-INH) preparations or to any ingredient in the formulation or component of the container
Haegarda (C1 Esterase Inhibitor Subcutaneous [Human . . . - RxList Haegarda (C1 Esterase Inhibitor Subcutaneous [Human] Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources
Haegarda for HAE: Usage, Dosage, Side Effects, Warnings Generic name: c1 esterase inhibitor subcutaneous (human) [ C1 ES-ter-ase-in-HIB-it-or ] Drug class: Hereditary angioedema agents Medically reviewed by Judith Stewart, BPharm Last updated on April 1, 2024 Uses Warnings Before taking Dosage Side effects Interactions FAQ What is Haegarda? Haegarda is a man-made form of a protein in blood that helps control swelling in the body People with a
HAEGARDA® Helps Prevent Hereditary Angioedema (HAE) Attacks HAEGARDA ®, C1 Esterase Inhibitor Subcutaneous (Human), is an injectable medicine used to prevent swelling and or painful attacks in patients 6 years of age and older with Hereditary Angioedema (HAE)
Drug Details | Haegarda - Injection It contains the active ingredient C1 Esterase Inhibitor (Human), which is a protein that helps regulate the complement system in the body Haegarda is administered through subcutaneous injections and is prescribed to individuals with HAE to reduce the frequency, severity, and duration of angioedema attacks